Moleculin Biotech is trading 15.37% up at $0.69, moving higher alongside a risk-on market backdrop fueled by Nvidia’s strong results and outlook.
- The Nasdaq Composite is up 0.90%, while the S&P 500 is up 0.34%.
- No new company-specific announcement dated August 27, 2026, was identified.
- Moleculin’s latest major update was its August 14 quarterly report and MIRACLE trial progress.